Loading...
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib
BACKGROUND: Low skeletal muscle mass is significantly associated with severe adverse events (AEs) from chemotherapy, and low tolerability leads to decreased survival. We aimed to investigate whether body skeletal muscle mass is correlated with tolerability and prognosis in patients with hepatocellul...
Na minha lista:
| Udgivet i: | Liver Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7206580/ https://ncbi.nlm.nih.gov/pubmed/32399433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504604 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|